We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$14.4B
AUM Growth
+$1.36B
Cap. Flow
+$273M
Cap. Flow %
1.9%
Top 10 Hldgs %
37.21%
Holding
1,342
New
30
Increased
738
Reduced
241
Closed
27

Top Buys

Rank Stock Value
1
VICI icon
VICI Properties
VICI
+$79.2M
2
DLR icon
Digital Realty Trust
DLR
+$75.4M
3
SPG icon
Simon Property Group
SPG
+$73M
4
INVH icon
Invitation Homes
INVH
+$60.9M
5
REXR icon
Rexford Industrial Realty
REXR
+$44.2M

Top Sells

Rank Stock Value
1
LAMR icon
Lamar Advertising Co
LAMR
+$81.1M
2
PSA icon
Public Storage
PSA
+$63.6M
3
DOC icon
Healthpeak Properties
DOC
+$53.3M
4
SUI icon
Sun Communities
SUI
+$47.6M
5
KIM icon
Kimco Realty
KIM
+$34.4M

Sector Composition

Rank Sector Weight
1 Real Estate 55.05%
2 Technology 11.48%
3 Consumer Discretionary 4.63%
4 Healthcare 4.39%
5 Communication Services 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LEGN icon
1076
Legend Biotech
LEGN
$3.65B
$13K ﹤0.01%
261
– –
OUT icon
1077
Outfront Media
OUT
$5.75B
$13K ﹤0.01%
820
+86
+12% +$1.51K
ACAD icon
1078
Acadia Pharmaceuticals
ACAD
$4.51B
$12K ﹤0.01%
651
– –
AKAM icon
1079
PUT
Akamai
AKAM
$15.6B
$12K ﹤0.01%
+500
New +$40.5K
PCVX icon
1080
Vaxcyte
PCVX
$7.65B
$12K ﹤0.01%
318
– –
VIR icon
1081
Vir Biotechnology
VIR
$1.46B
$12K ﹤0.01%
535
– –
ISEE
1082
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$12K ﹤0.01%
485
– –
ARWR icon
1083
Arrowhead Research
ARWR
$12.1B
$11K ﹤0.01%
426
– –
AXSM icon
1084
Axsome Therapeutics
AXSM
$11.7B
$11K ﹤0.01%
175
– –
BPMC
1085
DELISTED
Blueprint Medicines
BPMC
$11K ﹤0.01%
241
– –
PACB icon
1086
Pacific Biosciences
PACB
$435M
$11K ﹤0.01%
909
– –
RARE icon
1087
Ultragenyx Pharmaceutical
RARE
$2.46B
$11K ﹤0.01%
282
– –
RVNC
1088
DELISTED
Revance Therapeutics, Inc.
RVNC
$11K ﹤0.01%
331
– –
VIEW
1089
DELISTED
View, Inc. Class A Common Stock
VIEW
$11K ﹤0.01%
378
+74
+24% +$3.06K
RETA
1090
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$11K ﹤0.01%
126
+18
+17% +$1.06K
GH icon
1091
Guardant Health
GH
$19.1B
$10K ﹤0.01%
412
– –
SAGE
1092
DELISTED
Sage Therapeutics
SAGE
$10K ﹤0.01%
239
– –
ABCL icon
1093
AbCellera Biologics
ABCL
$1.65B
$9K ﹤0.01%
1,151
– –
BEAM icon
1094
Beam Therapeutics
BEAM
$2.68B
$9K ﹤0.01%
283
– –
INSM icon
1095
Insmed
INSM
$22.4B
$9K ﹤0.01%
545
– –
PRTA icon
1096
Prothena Corp
PRTA
$448M
$9K ﹤0.01%
195
– –
XENE icon
1097
Xenon Pharmaceuticals
XENE
$6.1B
$9K ﹤0.01%
252
– –
ZLAB icon
1098
Zai Lab
ZLAB
$2.07B
$9K ﹤0.01%
278
– –
MRTX
1099
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$9K ﹤0.01%
232
– –
AMLX icon
1100
Amylyx Pharmaceuticals
AMLX
$2.19B
$8K ﹤0.01%
266
– –
42 43
44
45 46

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q1 2023 Portfolio in Review

As of Q1 2023, Daiwa Securities Group held 1,342 positions worth $14.4B, up 10% from $13B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 4.2%. Daiwa Securities Group opened 30 new positions and exited 27, leaving the 1,342-position portfolio largely intact.

By sector, the portfolio is most concentrated in Real Estate at 55% of assets, down from 58% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q1 2023 buy was Global X Aging Population ETF: 800,000 shares worth $21.4M.
  • Daiwa Securities Group added most to VICI Properties in Q1 2023, an estimated $79.2M increase.
  • Daiwa Securities Group's biggest Q1 2023 reduction was Lamar Advertising Co, cutting an estimated $81.1M.
  • Daiwa Securities Group fully exited NextEra Energy, Inc. 5.279% Corporate Units in Q1 2023, selling an estimated $15.2M.
  • Daiwa Securities Group's ten largest holdings make up 37% of its $14.4B portfolio in Q1 2023.
  • Daiwa Securities Group opened 30 new positions and closed 27 in Q1 2023.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $14.4B.

Based on Daiwa Securities Group's 13F filing for Q1 2023, filed 2 May 2023.